Stay updated on Insulin Degludec in Symptomatic Nocturnal Hypoglycaemia Clinical Trial

Sign up to get notified when there's something new on the Insulin Degludec in Symptomatic Nocturnal Hypoglycaemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Insulin Degludec in Symptomatic Nocturnal Hypoglycaemia Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record regarding the effect of Insulin Degludec on the risk of symptomatic nocturnal hypoglycaemia in subjects with Type 1 Diabetes and high risk of severe hypoglycaemia.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:50.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a detailed description of 'Participation Criteria,' explaining that researchers look for people who fit specific eligibility criteria, such as general health condition or prior treatments. The new text also provides examples and directs users to read 'Learn About Studies' for general information about clinical research.
    Difference
    17%
    Check dated 2024-05-22T21:19:16.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:27:54.000Z thumbnail image

Stay in the know with updates to Insulin Degludec in Symptomatic Nocturnal Hypoglycaemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Insulin Degludec in Symptomatic Nocturnal Hypoglycaemia Clinical Trial page.